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ABSTRACT
Objective: To investigate the feasibility of a full-scale
randomised controlled trial of a picture booklet to
improve quality of life for people with epilepsy and
learning disabilities.
Trial design: A randomised controlled feasibility trial.
Randomisation was not blinded and was conducted
using a centralised secure database and a blocked 1:1
allocation ratio.
Setting: Epilepsy clinics in 1 English National Health
Service (NHS) Trust.
Participants: Patients with learning disabilities and
epilepsy who had: a seizure within the past 12 months,
meaningful communication and a carer with sufficient
proficiency in English.
Intervention: Participants in the intervention group
used a picture booklet with a trained researcher, and a
carer present. These participants kept the booklet, and
were asked to use it at least twice more over 20 weeks.
The control group received treatment as usual, and
were provided with a booklet at the end of the study.
Outcome measures: 7 feasibility criteria were used
relating to recruitment, data collection, attrition,
potential effect on epilepsy-related quality of life
(Epilepsy and Learning Disabilities Quality of Life Scale,
ELDQOL) at 4-week, 12-week and 20-week follow-ups,
feasibility of methodology, acceptability of the
intervention and potential to calculate cost-
effectiveness.
Outcome: The recruitment rate of eligible patients was
34% and the target of 40 participants was reached.
There was minimal missing data and attrition. An
intention-to-treat analysis was performed; data from the
outcome measures suggest a benefit from the
intervention on the ELDQOL behaviour and mood
subscales at 4 and 20 weeks follow-up. The booklet and
study methods were positively received, and no adverse
events were reported. There was a positive indication of
the potential for a cost-effectiveness analysis.
Conclusions: All feasibility criteria were fully or partially
met, therefore confirming feasibility of a definitive trial.
Trial registration number: ISRCTN80067039.
INTRODUCTION
People with learning disabilities (∼1.5
million people in the UK) face an increased
risk of health problems, poorer outcomes
than in the general population and prema-
ture, avoidable deaths.1–3 Epilepsy is the most
common neurological condition for people
with learning disabilities4 with a prevalence
rate of 22%,5 compared with 0.4–1% of the
general population, which increases with the
severity of the learning disability.6
Epilepsy in people with learning disabilities
typically begins in childhood, and has a
complex presentation, with people often
experiencing frequent seizures, generalised
seizures and multiple seizure types.7 Poorly
controlled and severe seizures are more
likely than in the general population with
∼70% of people with learning disabilities
Strengths and limitations of this study
▪ This feasibility study is the first completed ran-
domised controlled trial addressing the unmet
information and self-management needs of
people with learning disabilities and epilepsy.
▪ Effective collaboration with local clinical services
and patient and public representatives facilitated
recruitment to target.
▪ A mixed-methods design clearly addressed the
feasibility criteria and highlighted improvements
for a definitive trial through quantitative and
qualitative data.
▪ Despite efforts to recruit people with severe
learning disabilities, this population are under-
represented in the study.
▪ There were important variations in the extent that
carers involved participants in the question-
naires, and how the booklet was used, which
cannot be examined in a feasibility study.
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and epilepsy continuing to have seizures despite taking
antiepileptic medication.7 8 Comorbid health and
mental health issues as well as cognitive impairment can
make the management of epilepsy difﬁcult.9 This can
have a negative impact on care needs, daily activities,
work, quality of life, instances of hospitalisation, mortal-
ity and health and social care costs.10–15
Guidance from the National Institute for Health and
Care Excellence (NICE) in England states that people
with learning disabilities and epilepsy should be offered
the same services, investigations and care as the general
population, as well as information and support that is
tailored to their needs in order to promote autonomy
and empowerment.16 However, this group continue to
experience poor access to diagnostic investigations
and specialist services; access to services with appropriate
expertise appears to be highly dependent on
location.7 15 17 18
People with learning disabilities are often excluded
from clinical trials19 resulting in a weak evidence base
for effective treatment and services for this population.
This is particularly evident in epilepsy research,12 illu-
strated by a recent review of service responses for epi-
lepsy in learning disabilities which identiﬁed no
evaluations using randomisation or a matched compari-
son group.15 Despite calls for non-pharmacological inter-
ventions to be used alongside antiepileptic medication,20
there is little evidence for the effectiveness of such inter-
ventions due to the lack of robust trials in this area.21
People with learning disabilities and epilepsy often
lack appropriate skills training to manage their epilepsy,
as well as provision of accessible information.12 18 There
is also a need to improve communication between
healthcare professionals and people with learning dis-
abilities regarding decision-making about epilepsy man-
agement.12 In the general population, self-management
interventions have been found to improve people’s
understanding and management of epilepsy along with
their tolerability and adherence to medication.22–24 In
contrast, self-management interventions are rarely imple-
mented or evaluated with people with learning disabil-
ities and epilepsy.15 25 Such interventions have potential
to improve knowledge and epilepsy management, with a
likely improvement in quality of life.
‘Getting on With Epilepsy’ is a picture booklet
designed for people with learning disabilities and epi-
lepsy,26 and is part of the Beyond Words series of book-
lets.27 This booklet tells the story of a young adult with
epilepsy, and promotes understanding of epilepsy, self-
management and empowerment. The booklet uses pic-
tures rather than words to tell a story. It is suitable for
people with a range of communication styles and capita-
lises on the visual literacy and pictorial superiority of
people with learning disabilities, who tend to process
and assimilate pictorial information better than textual
information.28–30 The range of Beyond Words booklets
are popular and have received awards, but have not, as
yet, been evaluated in a controlled study, nor routinely
adopted in the health or social care sector in the UK.
The epilepsy picture booklet has the potential to be an
inexpensive and simple way of addressing the informa-
tion and self-management needs of people with learning
disabilities and epilepsy.
The objectives of the Wordless Intervention for Epilepsy
in Learning Disabilities (WIELD) randomised controlled
feasibility trial (feasibility RCT) were to:
1. Assess the feasibility of undertaking a RCT of the
picture booklet as an intervention for epilepsy in
people with learning disabilities.
2. Explore the feasibility of collecting resource use and
quality of life data so as to inform the design of the
health economics component of a future deﬁnitive
trial.
3. Assess the study procedures’ and intervention’s
acceptability among adults with learning disabilities,
carers and health professionals.
The full protocol for this study has previously been
published.31
METHODS
Design and setting
The study had a two-arm, single-centre parallel design,
and was conducted at one National Health Service
(NHS) Trust in England where participants were
Hertfordshire Partnership University NHS Foundation
Trust (HPFT) patients over a 20-month period from July
2014 to February 2016. Participants were recruited
through seven epilepsy clinics, and then randomised to
the intervention or control group.
Participants
Eligible patients were 18 years of age or over, with a con-
ﬁrmed clinical diagnosis of a learning disability (IQ≤70)
and epilepsy. Patients had to have experienced at least
one seizure over the previous 12 months and have mean-
ingful verbal or non-verbal communication which was
operationalised as being able to tell or follow the story
in the picture booklet. Originally, only patients with
verbal communication were eligible. This was changed
before the start of recruitment based on feedback from
patient representatives, carers and health professionals.
The carers of the patients had to be sufﬁciently proﬁ-
cient in English to read and complete the study ques-
tionnaires. Patients were excluded if they had a visual
impairment or dementia, or if they had used the picture
booklet within the past 12 months.
A subgroup of participants and their carers were
invited to take part in a semistructured interview after
completion of the ﬁnal follow-up assessment to explore
feasibility and acceptability of the study and interven-
tion. Random sampling was originally proposed, but this
was modiﬁed to purposeful sampling to ensure a range
of views and backgrounds were represented. A sample of
health professionals were also invited to participate in a
semistructured interview.
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Consent
Eligible patients were identiﬁed by epilepsy nurses and
consultant psychiatrists who ran epilepsy clinics at HPFT.
A log of eligible patients was created using the inclusion
and exclusion criteria. These patients were then con-
tacted to invite them to take part in the study through a
postal invitation pack containing standard and easy-read
information (see online supplementary material for
easy-read information sheet). This was then followed up
with a phone call ∼1 week later. A researcher subse-
quently visited interested patients and carers to discuss
the study. If the patient had capacity to decide whether
to participate, they completed an easy-read consent
form. If the carer felt that the patient did not have cap-
acity, a consultee declaration form was used. Originally
the visit was stated to occur at an epilepsy clinic but this
was changed, before recruitment started, to allow
patients and carers to choose to be seen at their home if
that was convenient. The original proposal also stated
that consenting, randomisation, data collection and the
intervention would all be conducted by a researcher
with a research nurse background. In order to maximise
recruitment, this was changed during the study to allow
a trained clinical studies ofﬁcer to also take on this role.
Randomisation and blinding
Participants were randomly allocated individually online
by a researcher using a database on a secure website.
The randomisation (1:1 allocation ratio) was ‘blocked’
into groups of six. Owing to the nature of the interven-
tion, it was not possible for the participants or research
team to be blind to group allocation.
Intervention
The researchers who conducted the intervention
received training from Beyond Words about how to use
the booklet. Participants in the intervention condition,
along with their carer, met the researcher at a conveni-
ent location. During this meeting, the ‘Getting on With
Epilepsy’ booklet was introduced. This involved the par-
ticipant going through the booklet at their own pace
and being encouraged to talk about what they could see
and how they felt, as appropriate.
As well as verbal guidance on how to use the booklet,
the participant and carer were advised that there was
further guidance and resources at the back of the
booklet, and they were given further information pro-
duced by Beyond Words. Participants kept the booklet,
and were asked to look at the booklet at least twice more
at home over the 20-week study period. Participants or
carers received a phone call ∼2 weeks later to discuss
any issues they may have had with the booklet. The dur-
ation of all contact between researcher, participant and
carer was noted by the research team, in order to esti-
mate the cost of the intervention.
Participants in the control condition received routine
information and services. At the end of the study,
control group participants were provided with a copy of
the booklet and information about how to use it.
Outcome measures
The feasibility criteria were developed a priori to reﬂect
key aspects of the study which would be necessary for a
full-scale trial. The seven feasibility criteria were:
▸ Rate of eligible patients recruited is higher than 60%.
▸ At least 80% of study measures have been completed.
▸ Discontinuation rates fall under 20%.
▸ The likely location of the improvement in the
primary outcome (quality of life) is at least 10%.
▸ Good feasibility and acceptability of the study
methodology.
▸ Good acceptability of the intervention among partici-
pants, carers and health professionals.
▸ Collection of resource use and quality of life data is
feasible, and the increase in treatment cost will be
minimal.
Each participant was assessed at baseline (T0), and at
4 (T1), 12 (T2) and 20 (T3) weeks after randomisation
(ﬁgure 1) using the outcome measures detailed in
table 1. The primary outcome measure was the Epilepsy
and Learning Disabilities Quality of Life Scale
(ELDQOL).32 33 Seizure severity and control were sec-
ondary outcomes, as improved management of epilepsy
has the potential to reduce seizures. Information was
also collected about how often the intervention group
participants used the booklet, how long for and who
with. Participants were asked about any other epilepsy
resources they had used, to explore whether booklet use
led to further information-seeking.
The study questionnaires were designed to be com-
pleted by the carer with the participant’s input, where
possible. The baseline questionnaire was completed with
a researcher present. The follow-up questionnaires were
sent and returned by post.
The semistructured interview schedule for the health
professionals and participants and carers aimed to
explore the acceptability of the study design and inter-
vention and perceived feasibility of using the booklet
in a routine care setting. The interview schedule also
explored the self-management, information and support
needs of participants, in relation to their experience of
epilepsy, and this is reported elsewhere.35
Sample size
One of the study objectives was to assess variation in the
ELDQOL in order to determine whether the interven-
tion is likely to achieve a 10% increase in the partici-
pants’ quality of life and to allow exclusion of an effect
size of <0.36 Ten per cent equates to an effect size of
∼0.4. In a full-scale trial, this would require a total
sample size of 174 (1−β=0.8, α=0.05), which indicates a
sample size of 16 per group (eg, 9% per group) in the
feasibility study. Assuming a conservative 25% drop out,
the recruitment target was a sample size of 20 per group
(40 participants in total). For the qualitative aspect of
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the study, we aimed to interview a subgroup of 15 partici-
pants and carers.
Data analysis
The analysis aimed to determine the feasibility of con-
ducting a full-scale RCT by addressing the objectives and
feasibility criteria outlined in table 2.
Quantitative data analysis was undertaken on Stata
V.13 (StataCorp. Stata Statistical Software: Release 13.
College Station, Texas: StataCorp LP; 2013). Most ana-
lysis was descriptive to evaluate the ﬂow of patients
through the study, the proportion of missing question-
naires, demographics of participants, use of the picture
booklet and seizure control. For the primary outcome,
ELDQOL, the variability of the scores for the four sub-
scales were estimated at each follow-up time point in
line with Cocks and Torgerson.36 Cohen’s d effect sizes
for the difference between the two groups were calcu-
lated. The 80% CIs of the effect sizes were examined to
determine whether they excluded an effect size of zero,
that is, an indication of a difference between the two
groups, and included the target effect size, that is, a
10% advantage for the intervention group.
For the health economic analysis, levels of resource use
associated with the booklet, intervention staff training,
face-to-face meetings (including travel), and the 2-week
follow-up call were recorded, and unit costs (£GBP for
the 2013–2014 ﬁnancial year) were subsequently assigned
Figure 1 Study flow chart.
4 Mengoni SE, et al. BMJ Open 2016;6:e012993. doi:10.1136/bmjopen-2016-012993
Open Access
group.bmj.com on November 11, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
to all items.37–40 The total costs were then apportioned
across all participants in the intervention arm, in order to
estimate mean per participant cost of the intervention. In
order to estimate overall cost to the NHS, Personal Social
Services (PSS), and informal care, the carer was asked to
complete a resource use questionnaire at baseline and
20-week follow-up.
Health-related quality of life was estimated using
the EuroQol EQ-5D-5L questionnaire,34 a generic
preference-based measure. EQ-5D-5L data were con-
verted into utility scores (a scale where zero is equal to
death and one is full health)41 using a mapping approach
based on the three-level version.42 Quality-adjusted life
year (QALY) scores were subsequently calculated using
the area under the curve approach.43 As this was a
feasibility study, the main focus was on completion rates.
A preliminary within-trial analysis (using bivariate regres-
sion,44 based on a complete-case analysis45) was also con-
ducted over the 20-week follow-up period, though these
results need to be treated with caution due to small
numbers. The incremental cost-effectiveness ratio
(ICER), deﬁned as mean incremental cost/mean incre-
mental effect, was subsequently estimated.41 NICE gener-
ally deems interventions which have an ICER below
£20 000 per QALY as cost-effective.46
The semistructured interviews were transcribed
and analysed using thematic content analysis47 on
NVivo V.11. Two members of the research team coded
the interviews, with 30% of the interviews being
coded by both researchers. Codes were compared and
then discussed, and themes were derived through
discussion.
Table 1 Study outcome measures
Outcome Data collection method
T0
Baseline
T1
Week 4
T2
Week 12
T3
Week 20
Number of eligible patients and
number recruited
Case report form ✓
Discontinuation rates across both
groups and reasons
Case report form ✓ ✓ ✓ ✓
Demographic data Questionnaire: context-specific questions
about age, sex, ethnicity, and living
circumstances of the participant, the type
of care provided by the carer and their
relationship to the participant
✓
Patterns of use of the Beyond Words
booklet (intervention group only)
Questionnaire: context-specific questions ✓ ✓ ✓
Use of other epilepsy-related
information
Questionnaire: context-specific questions ✓ ✓
Quality of life as the primary
outcome measure
Questionnaire: ELDQOL scale, which
consists of four subscales: behaviour,
seizure severity, mood and side
effects32 33
✓ ✓ ✓ ✓
Seizure severity as a secondary
outcome measure
Questionnaire: ELDQOL seizure severity
subscale
✓ ✓ ✓ ✓
Seizure control as a secondary
outcome measure
Seizure diary ✓
Health-related quality of life Questionnaire: EQ-5D-5L index and visual
analogue scale (EQ-VAS)—proxy
version34
✓ ✓ ✓ ✓
Health and social services and
resources use
Questionnaire: context-specific resource
use questions
✓ ✓
Feasibility and acceptability of the
study procedures
Semistructured interview ✓
Use and perceived usefulness of
existing resources and services
Semistructured interview ✓
Information and self-management
support needs
Semistructured interview ✓
Perceived acceptability of the
intervention
Semistructured interview ✓
Perceived barriers and facilitators to
the use and dissemination of the
intervention in routine care
Semistructured interview ✓
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Table 2 Objectives, feasibility criteria and key findings
Objectives Feasibility criteria (if applicable)
Feasibility criterion met
and suggested
amendments if not met Outcome
Evaluate the recruitment rate and number
of eligible patients recruited (quantitative)
Feasibility criterion 1: rate of eligible
patients recruited is higher than 60%
Criterion not met overall
(although target recruitment
was met)
Amendments:
▸ Extend recruitment period
▸ Develop materials to
increase recruitment of
patients with severe
learning disabilities
▸ Target recruitment was met (n=40)
▸ Per cent of patients recruited from all those
screened: 25%
▸ Per cent of patients recruited from eligible screened
patients: 34%
Evaluate completion rates (quantitative) Feasibility criterion 2: at least 80% of
study measures have been
completed
Criterion met ▸ 85% of all study measures were completed.
Measure discontinuation rates across both
arms (quantitative)
Feasibility criterion 3: discontinuation
rates fall under 20%
Criterion met ▸ No discontinuations with the exception of one
death (unrelated to the study)
Assess the variability of the primary
outcome measure (quality of life)
(quantitative)
Feasibility criterion 4: the likely
location of the improvement in the
primary outcome (quality of life) is at
least 10%.
Criterion partially met
Amendments:
▸ Omit medication subscale
▸ Develop an epilepsy
knowledge measure
▸ The 80% CI of the effect size excludes zero in
favour of the intervention group on ELDQOL
behaviour (T1; T3) and mood subscales (T1; T3).
▸ The 80% CI of the effect size includes the target
effect size (10% improvement) for ELDQOL
behaviour (T3).
Assess the feasibility and acceptability of
the study methodology (qualitative)
Feasibility criterion 5: good feasibility
and acceptability of the study
methodology
Criterion met ▸ Qualitative data indicated high acceptability and
feasibility of the study methods.
Explore potential weaknesses of the study
design (qualitative)
Suggestions for improvements have been identified,
for example,
1. Reduce and alter questionnaire material
▸ Remove 12-week follow-up assessment as
there was most missing data (23%)
▸ Remove medication side-effects subscale of
ELDQOL
▸ Develop and add epilepsy knowledge measure
2. Provide several completion formats for follow-up
questionnaires
▸ Option to complete an online questionnaire or
answer questions over the phone
3. Minimise missing data at 20 weeks
▸ 20-week questionnaire will be completed during a
study visit with the research nurse
4. Understand how booklet is used by participants
and carers
Continued
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Table 2 Continued
Objectives Feasibility criteria (if applicable)
Feasibility criterion met
and suggested
amendments if not met Outcome
▸ Conduct observations of booklet use at 20-week
follow-up
Explore the acceptability of the Beyond
Words booklet (qualitative)
Feasibility criterion 6: good
acceptability of the intervention
among participants, carers and health
professionals
Criterion met ▸ High levels of acceptability of the booklet in
intervention group
▸ Use of booklet perceived to be feasible in routine
care
To explore the feasibility of collecting
resource use and quality of life data
(quantitative)
Feasibility criterion 7: collection of
resource use and quality of life data
is feasible, and the increase in
treatment cost will be minimal.
Criterion partially met
amendments:
▸ Costs may be lower in a
full-scale trial as the
training costs are
apportioned per
participant.
▸ Good rates of data completion and minimal data
cleaning was required.
▸ The mean per participant cost of the intervention
was £122.
▸ Preliminary cost-effectiveness analysis indicates no
significant difference between the two groups.
Monitor the intervention’s patterns of use
postrandomisation, and explore whether
other resources on epilepsy have been
used (quantitative)
▸ 86% of participants used the booklet at least once
more at home.
▸ The number of participants in the intervention
group (n=21) reporting to have used the
intervention on the follow-up questionnaires
decreased over time from 15 (4 weeks) to 12
(12 weeks) to 10 (20 weeks)
▸ Minimal use of other education/information
resources
ELDQOL, Epilepsy and Learning Disabilities Quality of Life Scale.
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RESULTS
Four out of seven criteria used to determine the feasibil-
ity of a full-scale trial were fully met (table 2). Three
criteria were partially met. Amendments to the study
design and methodology have been identiﬁed and
would be implemented in a deﬁnitive trial. The partici-
pant ﬂow diagram for the study can be seen in ﬁgure 1.
Recruitment
Recruitment began in July 2014 and was originally
scheduled to be completed by December 2014. The
recruitment period was extended by 4 months to com-
pensate for logistical issues that caused delays at the
study onset. The target of 40 participants was met in
April 2015, without delaying the planned study comple-
tion date. All participants and carers chose to be visited
at home by the researcher. Follow-up data collection
continued until September 2015, and this is when parti-
cipants’ involvement in the study ended.
The ﬁrst feasibility criterion was to randomise 60% of
eligible patients. The study recruited 25% of all
screened patients (n=160) and 34% of screened patients
who were eligible (n=118). Despite not meeting this
feasibility criterion, the study recruited to target without
delay to the study end date.
The most common reasons for being excluded from
the trial was the carer reporting that the patient would
be unable to use the booklet due to communication
issues or an absence of seizures within the past
12 months. There was a range of reasons for people
declining to take part, although approximately half of
the carers/patients did not give a reason.
The characteristics of participants across the two
groups can be seen in table 3. There are some differ-
ences between the groups. In particular, the interven-
tion group had had their epilepsy diagnosis for fewer
years. They were also slightly younger and received fewer
hours of care from their carer.
Data collection
The proportion of completed study measures was 85%
with most missing data at T2 (23%), thus meeting the
second feasibility criterion overall (at least 80% of study
measures completed). The proportion of missing data
was similar across the two groups. Two participants did
not complete any follow-up questionnaires (T1–T3), but
did not ask to withdraw from the study (despite the
opportunity to do so).
Discontinuation rates
No participants withdrew from the trial. One participant
died over the course of the study, unrelated to study par-
ticipation. One participant was considered not to have
received the intervention as they refused to look at the
booklet with the research nurse and with their carer at a
later date. An intention-to-treat analysis was carried out,
including these participants. Therefore, the third feasibil-
ity criterion (discontinuation rates under 20%) was met.
Intervention effect on primary and secondary outcomes
The intervention group generally reported higher scores
at baseline (T0) compared with the control group on
the ELDQOL, indicating poorer quality of life.
Therefore, adjusted means for the follow-up time points
were calculated controlling for baseline differences.
Effect sizes were then calculated for the group differ-
ence for the outcome measures, along with 80% CIs.
Table 4 shows the baseline mean scores and SDs,
adjusted T1–T3 mean scores and CIs, along with effect
sizes and CIs. Examination of effect sizes and CIs indi-
cated a signal of a positive effect from the intervention
on the behaviour and mood subscales of the ELDQOL
at T1 and T3. On subscales for behaviour, mood and
seizure severity (secondary outcome) at T2, there was
indication of improved scores in the control group. This
ﬁnding is unexpected and there is no theoretical ex-
planation; the most likely reason for this ﬁnding is the
relatively small sample size at T2 due to the largest pro-
portion of missing data being at this time point (23%).
Participants reported difﬁculties completing the
ELDQOL medication subscale. Respondents were often
unable to determine whether a behaviour was caused by
epilepsy medication (and could therefore be identiﬁed
as a side effect of epilepsy medication), or was due to
other medication or other reasons. Furthermore, the
seizure subscale was only completed for participants who
had experienced a seizure over the previous 4 weeks.
The sample size was often very low: 8–11 people in the
Table 3 Demographics of participants
Control group
(n=19)
Intervention
group (n=21)
Gender
Female:male 10:9 13:8
Age
Mean (SD) 44.68 (14.53) 39.00 (12.65)
Ethnicity
White 19 19
Bangladeshi 0 1
Black—other 0 1
Years since diagnosis*
Mean (SD) 39.31 (16.22) 23.38 (16.49)
Accommodation
Family home 6 3
Own property 0 1
Registered care
home
5 7
Supported
accommodation
8 9
Tenancy 0 1
Carer relationship to participant
Family member: paid
carer
6:13 5:16
Number of hours of care per week provided by carer
Median (IQR) 37 (35–168) 15 (10–168)
*Missing data=14.
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intervention group (n=21) and 10–13 people in the
control condition (n=19).
The fourth feasibility criterion (likelihood of improve-
ment in quality of life) can therefore be considered to
be partially met: indication of an effect of the interven-
tion on the two ELDQOL subscales (behaviour and
mood), at two out of three time points (T1 and T3),
with the most complete data.
Seizure control was a secondary outcome, and was
assessed through completion of a seizure diary during
the 20-week study period. If participants had not experi-
enced seizures over the previous 4 weeks, then they did
not complete the ELDQOL seizure severity subscale at
each time point. A sizeable minority of participants
reported having no seizures over the previous 4 weeks: a
mean of 38% in the intervention group compared with
25% in the control group. Similarly, more intervention
group participants than control group participants
experienced no seizures over the course of the study
(33% compared with 16%). As would be expected from
these results, the intervention group reported fewer sei-
zures over the 20-week study period than did the control
group (13.78 (95% CI −0.36 to 35.61), compared with
17.63 (95% CI 1.73 to 25.83)).
Acceptability and feasibility of methodology and
intervention
Interviews with 15 sets of participants and/or carers took
place at the 20-week time point and occurred between
January and September 2015. Eleven interviews took
place with both participant and carer(s), one participant
and their carer were interviewed separately, two inter-
views took place with the participant only and one inter-
view took place with the carer only. Interviews with four
health professionals took place between February and
November 2015. The health professionals were all
involved in the study, although this varied from close to
minimal involvement.
Table 5 shows the themes and subthemes regarding
the study methods and intervention from the interviews
with participants and carers, and the results indicate
that feasibility criteria 5 and 6 were met. Interviewees
were generally very positive about their experience of
the WIELD project and would recommend participating
in the study to others. Some areas for improvement were
suggested, for example, offering online questionnaire
completion, and reducing the length of the question-
naires. Participants and carers also identiﬁed speciﬁc
questions or subscales, which they found difﬁcult to
complete, and which tended to coincide with missing
data.
Participants and carers reported that they had
received little information about epilepsy in the past,
which was accessible for people with learning disabilities.
The booklet was generally received very positively by par-
ticipants and carers, and participants reported relating
the booklet to their own experiences. Participants and
carers felt that the epilepsy-related conversations
Table 4 ELDQOL mean scores, SDs and 95% CIs with T1–T3 adjusted for baseline
N Control group N Intervention group
Mean SD 95% CIs Mean SD 95% CIs
Effect size of the group
difference (80% CI)
ELDQOL seizure severity
T0 (baseline) 12 27.50 8.29 – 11 29.25 9.37 – –
T1 (4 weeks) 10 26.42 – 22.46 to 30.39 8 26.66 – 22.50 to 30.82 0.04* (−0.17 to 0.25)
T2 (12 weeks) 11 24.26 – 20.27 to 28.25 9 29.17 – 25.01 to 33.33 0.79* (0.43 to –1.15)
T3 (20 weeks) 13 25.62 – 21.68 to 29.56 8 27.06 – 22.68 to 31.44 0.21* (−0.02 to 0.44)
ELDQOL side effects
T0 (baseline) 11 71.56 4.93 – 15 65.99 10.75 – –
T1 (4 weeks) 12 65.66 – 50.02 to 72.29 17 65.98 – 60.84 to 71.12 0.03* (−0.13 to 0.19)
T2 (12 weeks) 13 66.57 – 60.10 to 73.05 15 65.15 – 59.84 to 70.46 0.12† (−0.06 to –0.30)
T3 (20 weeks) 11 64.54 – 57.65 to 71.43 14 64.87 – 59.60 to 70.14 0.03* (−0.14 to –0.20)
ELDQOL behaviour
T0 (baseline) 19 14.36 3.25 – 21 15.96 5.33 – –
T1 (4 weeks) 15 15.48 – 13.92 to 17.03 19 14.67 – 13.29 to 16.06 0.26† (0.07 to 0.45)
T2 (12 weeks) 15 14.39 – 12.83 to 15.95 16 15.25 – 13.78 to 16.71 0.28* (0.08 to 0.48)
T3 (20 weeks) 16 15.86 – 14.33 to 17.39 16 14.50 – 13.03 to 15.96 0.43† (0.21 to –0.65)
ELDQOL mood
T0 (baseline) 19 28.27 6.10 – 20 30.72 7.31 – –
T1 (4 weeks) 15 31.07 – 28.73 to 33.42 18 29.53 – 27.34 to 31.71 0.32† (0.12 to 0.52)
T2 (12 weeks) 15 30.64 – 28.27 to 33.00 16 31.62 – 29.32 to 33.93 0.21* (0.02 to 0.40)
T3 (20 weeks) 16 31.08 – 28.78 to 33.38 17 30.05 – 27.85 to 32.24 0.22† (0.04 to 0.40)
Higher scores reflect poorer quality of life.
*Effect size in favour of the control group.
†Effect size in favour of the intervention group.
ELDQOL, Epilepsy and Learning Disabilities Quality of Life Scale.
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prompted by the booklet were helpful, and revealed new
information. Several participants also noted that the
booklet helped them to further understand epilepsy and
to explain their condition to others. Participants with
well-controlled epilepsy felt that the intervention may be
more appropriate for people who had recently been
diagnosed, or had difﬁculties understanding or man-
aging their epilepsy. Some carers and participants felt
that they needed the guidance provided in the interven-
tion session in order to be able to use the booklet,
whereas others felt that they would be able to use the
booklet without this.
The interviews with health professionals largely sup-
ported the observations made by participants and carers
and suggested ways to improve the set-up and recruit-
ment phase of the study. Participating health profes-
sionals felt that carers needed support to use the
booklet appropriately. There were mixed views about the
group of participants who this intervention may be most
effective for. The booklet was reported to be more difﬁ-
cult to use with non-verbal participants, although the
health professionals acknowledged that the booklet was
designed for use with this population and this group
often had the most severe epilepsy. It was also suggested
that although the booklet had the potential to be useful
for all people with learning disabilities and epilepsy, it
may be most useful for people who had recently been
diagnosed.
In addition to the qualitative data, quantitative data
about the use of the booklet during the study were col-
lected. The intervention session took place in one sitting
and took ∼20 min. The majority of people in the inter-
vention group used the booklet at least twice after the
intervention session (n=14), with three participants
never using the booklet at home. The number of people
reporting to have used the booklet at home since the
previous questionnaire decreased over the course of the
study from 15 at T1, to 12 at T2, and to 10 at T3. The
frequency and time spent using the booklet also
decreased over time. At T3 those who were still using
the booklet reported to be doing so with a wider range
of people than at T1. There were no reported harms or
unintended effects in either group.
Health economic analysis
Across the 21 intervention patients, the mean per par-
ticipant cost of the intervention was estimated to be
£121.56, where this was composed of training costs
Table 5 Key themes about acceptability and feasibility from the interviews with participants and carers
Themes Subthemes
Feasibility and acceptability of
participation
▸ Most people enjoyed taking part in WIELD and would recommend it to others.
▸ Most people understood the need for random allocation and accepted this was
part of the study.
▸ Study information explained the study well and was suitable for most participants.
▸ Study visit went well and everything was explained clearly.
Feasibility and acceptability of data
collection methods
▸ Completing the questionnaires four times was fine for most people.
▸ Most participants were involved in completing the questionnaires.
▸ Most people felt that the questions and language were clear but there was some
room for improvement.
▸ Postal questionnaires were fine for most people but it would be helpful to have
options to complete the questionnaire online, on the phone or at a visit.
▸ Some carers and participants sometimes found it challenging to find the time to
complete the questionnaires.
▸ Some people completed the seizure diary but others did not.
▸ Some people thought the questionnaires were quite long but this was not a
problem for most people.
▸ Specific questions could be difficult to answer.
Use and acceptability of the booklet ▸ A minority of carers and participants were already familiar with Beyond Words.
▸ Most participants engaged with the booklet and could identify benefits.
▸ Control participants had differing views on the booklet after first looking at it.
▸ The booklet was used in different ways.
Feasibility of routine use of the booklet ▸ Mixed feelings about level of support needed to use the booklet.
▸ Need to be aware if person with learning disabilities is anxious as the booklet
could make this worse.
▸ The booklet could be implemented in the health and social care system.
▸ The booklet could be useful for other people with epilepsy.
▸ The booklet is useful for people with difficulties with verbal communication.
▸ The booklet may be most useful when someone has just been diagnosed.
▸ The booklet may be particularly helpful to explain epilepsy to others.
▸ The time needed to use the booklet could be a barrier.
WIELD, Wordless Intervention for Epilepsy in Learning Disabilities.
10 Mengoni SE, et al. BMJ Open 2016;6:e012993. doi:10.1136/bmjopen-2016-012993
Open Access
group.bmj.com on November 11, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
(£28.42 per participant), an initial meeting cost (£72.14
per participant, based on a 21 min meeting with travel
time and costs included), a follow-up phone call (£11.00
per participant) and the cost of the book (£10.00). The
seventh feasibility criterion states that a minimal increase
in treatment cost should be evident; therefore, we judge
this to be partially met. However, we estimate that given
the research context, this cost is signiﬁcantly higher
than what it would cost to use the booklet in routine
care (eg, to be conservative all training costs were ap-
portioned across the small number of participants in
the intervention arm of the study). Paired cost and
EQ-5D-5L data were available for 29/40 participants at
the 20-week follow-up point (16 intervention, 13
control), demonstrating that it was generally feasible to
collect the economic data in the devised manner. All
subsequently reported results are based on these 29 par-
ticipants. Over the 20-week follow-up period, mean NHS
costs (excluding the cost of the intervention) were
£616.79 and £698.46 for the intervention and control
arm, respectively. Based on the regression analyses,
which adjusted for baseline costs and included the cost
of the intervention, over the 20-week follow-up period,
mean NHS costs were estimated to be £87.08 (95% CI
−375.77 to 549.94) higher for the intervention group
compared with the control group.
Total mean NHS, PSS and informal care costs (which
included residential costs, where applicable) were sub-
stantially higher and estimated to amount to £36 656.96
for the intervention and £45 430.40 for the control arm,
respectively. The mean cost difference between groups
was not estimated to be signiﬁcant (−£2663.39, 95% CI
−8480.29 to 3151.51). Quality of life as assessed by the
standard EQ-5D-5L questionnaire can be seen in table 6.
The mean QALY difference was −0.006 (95% CI −0.050
to 0.038). The corresponding EQ-5D visual analogue
scale (0–100 with higher scale indicating better quality of
life) was also similar between treatment groups. It can
therefore be seen that there was no signiﬁcant difference
between either the mean costs or QALY score for the
intervention group compared with the control group.
DISCUSSION
Principal findings
RCTs are the gold standard for evaluating interventions
and services. This study is the ﬁrst completed RCT
addressing the outstanding information and self-
management needs of people with learning disabilities
and epilepsy. Recruitment was extended by 4 months
and achieved the target, without delaying the study’s
end date. Eighty-ﬁve per cent of study measures were
completed and attrition was minimal (one death unre-
lated to study involvement and no other drop-out). A
potential effect of the intervention on two ELDQOL
subscales was found at 4 and 20 weeks. The acceptability
and feasibility of the methodology and intervention were
high among participants, carers and health profes-
sionals. Collection of economic data was found to be
feasible. All feasibility criteria were fully met (n=4) or
partially met (n=3) and qualitative and quantitative ﬁnd-
ings indicated improvements to the recruitment and
data collection procedures, thus conﬁrming the feasibil-
ity of undertaking a deﬁnitive trial.
Strengths and weaknesses
The strengths of this study were the rigorous rando-
mised controlled evaluation of the feasibility of this pic-
torial intervention. This approach has very rarely been
adopted before in the context of learning disabilities
research.15 Second, there were high levels of public and
patient involvement, including people with learning dis-
abilities and their carers, which signiﬁcantly strength-
ened the study design, management and dissemination
of the study ﬁndings.48 49 It is hoped that the successful
delivery of this study paves the way for further research
in this area with similarly robust methodology, supported
by continuous stakeholder involvement.
However, the following limitations need to be consid-
ered. First, the proportion of people with an epilepsy
diagnosis increases with the severity of learning disabil-
ities, with a recent prevalence estimate of 42% in people
with ‘more severe’ learning disabilities.5 Only four study
participants had limited or no verbal communication
Table 6 EQ-5D-5L mean scores, SDs and 95% CIs
Control group Intervention group
N Mean SD 95% CIs N Mean SD 95% CIs
EQ-5D-5L index
T0 (baseline) 19 0.461 – 0.301 to 0.621 21 0.611 – 0.480 to 0.743
T1 (4 weeks) 15 0.494 – 0.291 to 0.696 18 0.643 – 0.459 to 0.692
T2 (12 weeks) 14 0.497 – 0.263 to 0.731 16 0.594 – 0.436 to 0.752
T3 (20 weeks) 13 0.622 – 0.404 to 0.840 17 0.661 – 0.504 to 0.818
QALY 13 0.219 – 0.139 to 0.299 17 0.241 – 0.188 to 0.294
EQ-VAS
T0 (baseline) 19 77.37 16.45 – 21 70.62 27.30 –
T1 (4 weeks) 15 71.33 21.25 – 18 76.89 23.84 –
T2 (12 weeks) 15 83.67 17.78 – 16 74.88 20.17 –
T3 (20 weeks) 15 78.20 21.53 – 16 76.69 25.52 –
QALY, quality-adjusted life year; VAS, visual analogue scale.
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(two in each group), which is not representative of this
group of patients. During recruitment, it became clear
that many carers of patients with severe learning disabil-
ities and/or non-verbal communication felt that they
did not meet the inclusion criteria of being able to inter-
act with or follow the booklet’s story, although clinicians
had initially identiﬁed the patient as eligible during
screening (n=21). As the booklet was designed to be
used by people with a wide range of learning disabilities
and communication abilities, this would need to be
addressed in a full-scale trial by ensuring that the initial
material presented to carers highlights the study’s and
intervention’s suitability for people with severe learning
disabilities and/or limited verbal communication.
Second, this study relied on proxy completion of the
questionnaires, in order to standardise questionnaires
across all participants. From the qualitative data, it is
evident that carers involved people with learning disabil-
ities to different degrees and that some participants with
mild learning disabilities completed the questionnaires
independently. There is evidence to suggest that there
are differences in the responses of patients, family carers
and paid carers on questionnaires of epilepsy-related
concerns.50 51 In future work, the variation across differ-
ent respondents could be examined.
Research in context
People with learning disabilities are under-represented
in clinical trials, which results in a limited knowledge
base about effective healthcare interventions in a popu-
lation already experiencing health disparities.12 19 There
are modiﬁcations and adaptations that can be made to
study designs and procedures to minimise obstacles
including accessible information materials (eg, easy-read
formats were successfully used in WIELD—see online
supplementary material), simpliﬁed consent procedures,
modiﬁed procedures to allow support from carers and
simpliﬁed data collection materials.19 People with learn-
ing disabilities are positive about participating in
research and highlight the importance of researchers
understanding their experiences and opinions.52
Two key factors in this study facilitated successful
recruitment and high levels of acceptability of the
design. First, the study procedures and materials were
carefully designed with the feedback of people with
learning disabilities, carers, members of the public and
health professionals, which resulted in improved accessi-
bility. Second, the design of this study was closely
aligned with local epilepsy and learning disability ser-
vices, which facilitated recruitment. It is important for
clinical trials to be embedded within the relevant health
services to ensure successful recruitment and likelihood
of potential implementation.53 55 Services across England
for people with learning disabilities and epilepsy vary
greatly;15 the clinical care pathway in different NHS Trusts
may affect recruitment in a full-scale trial and routes to
implementation in routine care. Therefore, future
research and dissemination would need to continue to
work collaboratively with local services, and explore differ-
ent ways of using the booklet and how this may, or may
not, align with local practice.
A recent scoping review of self-management interven-
tions for people with learning disabilities and epilepsy25
identiﬁed a nurse-led intervention that is currently
underway,55 and three completed small-scale studies.56–58
The results of the completed studies are promising and
suggest that a self-management intervention could be
appropriate and beneﬁcial for people with learning dis-
abilities and epilepsy. However they are underpowered,
did not use a RCT design and did not assess outcomes on
quality of life or seizure control.
Implications for clinicians and policymakers
Very few of the study participants had ever received
information about epilepsy that was adapted to their
communication ability. Much of the information pro-
vided by health professionals was not easily accessible,
and was aimed at carers. The booklet was received posi-
tively and various beneﬁts were noted. This suggests
that there is a need for tailored education and self-
management information for people with learning disabil-
ities and epilepsy, which is currently unmet. The feasibility
ﬁndings are promising, but the results of a deﬁnitive trial
are necessary to demonstrate whether the proposed inter-
vention meets these needs, and improves outcomes.
The qualitative data suggested that some participants
experienced improvements from the intervention in
their epilepsy-related knowledge, conﬁdence and
anxiety. There is currently no measure that assesses
these constructs in people with learning disabilities and
epilepsy. Further research could explore this to under-
stand more about the needs of this population, and how
to meet these needs.
This study did not explore the ﬁdelity of the interven-
tion; in order to fully evaluate this intervention, it would
be crucial to ascertain whether the intervention is used
by participants and carers as recommended, and to
explore and understand the underlying mechanisms of
booklet use. A process evaluation approach using ethno-
graphic methods would be informative to observe how
the booklet is used, and what the ‘critical ingredients’ of
this intervention may be.
CONCLUSIONS
The WIELD study was completed with successful recruit-
ment and minimal missing data. Four out of seven feasi-
bility criteria were fully met, and three criteria were
partially met, thus conﬁrming the feasibility of undertak-
ing a deﬁnitive trial. Acceptability of the study methods
and intervention was high among participants, carers
and health professionals. By developing and testing
methods to reduce the number of follow-ups, extend the
recruitment period, develop study information material
to increase the involvement of participants with severe
learning disabilities and assess epilepsy knowledge,
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recruitment rates could increase and the effects of the
intervention could be measured more accurately. Given
the success of the feasibility study and robust evidence to
address any potential issues, it is clear that a deﬁnitive
trial is both feasible and necessary to address important
gaps in evidence-based practice for people with learning
disabilities and epilepsy.
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